Reduced immune responses to the Epstein-Barr virus may help explain the efficacy of anti-CD20 therapy in people with MS, per ...
A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than ...
Background The effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis (MS) declines with age, while ...
Hosted on MSN
Yaks may hold the key to treating MS patients: study
Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...
HOUSTON and WALTHAM, Mass., April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated ...
Newswise — WALTHAM, Mass., July 31, 2024-- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) announced today that it has named Stephanie Buxhoeveden, Ph.D., M.S.N., FNP-BC, MCSN, as its Chief ...
WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) with generous support from EMD Serono's Embracing Caregivers initiative, announced today the ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results